Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.

Saved in:

Bibliographic Details
Title:	Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells.
Authors:	Oh MH; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and.; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Sun IH; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and., Zhao L; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and., Leone RD; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and., Sun IM; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and., Xu W; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and., Collins SL; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and.; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Tam AJ; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and., Blosser RL; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and., Patel CH; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and., Englert JM; UPMC Enterprises, Pittsburgh, Pennsylvania, USA., Arwood ML; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and., Wen J; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and., Chan-Li Y; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Tenora L; Institute of Organic Chemistry and Biochemistry, Prague, Czech Republic., Majer P; Institute of Organic Chemistry and Biochemistry, Prague, Czech Republic., Rais R; Department of Neuroscience, Johns Hopkins Drug Discovery, Baltimore, Maryland, USA., Slusher BS; Department of Neuroscience, Johns Hopkins Drug Discovery, Baltimore, Maryland, USA., Horton MR; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Powell JD; Bloomberg~Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Research Center, Department of Oncology, and.
Source:	The Journal of clinical investigation [J Clin Invest] 2020 Jul 01; Vol. 130 (7), pp. 3865-3884.
Publication Type:	Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1558-8238
DOI:	10.1172/JCI131859